Guidelines for the Clinical and Economic Assessment of Health Technologies Journal Articles

abstract

• That new health technologies often diffuse into the health care systems of developed countries without adequate evaluation has long been a cause of concern (I). In addition, where clinical or economic assessments have been carried out, they often contain methodological weaknesses which reduce their usefulness to health policy makers or clinical practitioners (5,6).

authors

• Guyatt, Gordon
• Drummond, Michael

status

• published 

publication date

• July 1985

has subject area

• 1117 Public Health and Health Services (FoR)
• 1402 Applied Economics (FoR)
• Clinical Trials as Topic (MeSH)
• Cost-Benefit Analysis (MeSH)
• Health Policy & Services (Science Metrix)
• Magnetic Resonance Spectroscopy (MeSH)
• Outcome and Process Assessment, Health Care (MeSH)
• Technology Assessment, Biomedical (MeSH)

published in

• International Journal of Technology Assessment in Health Care  Journal

keywords

• Clinical Trials as Topic
• Cost-Benefit Analysis
• Magnetic Resonance Spectroscopy
• Outcome and Process Assessment, Health Care
• Technology Assessment, Biomedical

Digital Object Identifier (DOI)

• 10.1017/s0266462300001471

PubMed ID

• 10311549

start page

• 551

end page

• 566

volume

• 1

issue

• 3